Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force

Appendix 5. Key question 8 addresses costs and cost-effectiveness of screening, and key question 9 deals with the harms of screening.
Appendix 5. Key question 8 addresses costs and cost-effectiveness of screening, and key question 9 deals with the harms of screening. Selection of articles based on key questions 8 (top) and 9 (bottom).

This Article

  1. Ann Intern Med December 3, 2002 vol. 137 no. 11 917-929
  1. AbstractFREE
  2. Figures
  3. Full Text
  4. Full Text (PDF)

Current Issue

  1. November 17, 2009, 151 (10)
  1. Alert me to current issues